Search Within

Nayanendu Saha

Formats
  1. Journal Article (22)
  2. Review (1)
Groups
  1. Sloan Kettering Institute Faculty (23)
  2. Sloan Kettering Institute Postdocs (23)
  3. GSK Faculty (22)
  4. Structural Biology Program Faculty (18)
  5. Basic Research Innovation Award (BRIA) (4)
  6. Molecular Biology Program Faculty (4)

More Groups

People
  1. Dimitar Nikolov (18)
  2. Juha Himanen (10)
  3. Dorothea Robev (5)
  4. Momchil Kolev (4)
  5. Stewart Shuman (4)
  6. Elisa De Stanchina (3)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (2)
  5. 2021 (2)
  6. 2019 (1)

More Years

Publications
  1. Biomedicine and Pharmacotherapy (2)
  2. Cell (2)
  3. Journal of Biological Chemistry (2)
  4. Biochemical and Biophysical Research Communications (1)
  5. Cancer Letters (1)
  6. Cancers (1)

More Publications

Publishers
  1. Elsevier Inc. (5)
  2. American Society for Biochemistry and Molecular Biology (2)
  3. Cell Press (2)
  4. Elsevier Ireland Ltd. (2)
  5. Elsevier Science, Inc. (2)
  6. MDPI (2)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antibodies targeting ADAM17 reverse neurite outgrowth inhibition by myelin-associated inhibitors
    Journal Article

    Saha, N.; Chan, E.; Mendoza, R. P.; Romin, Y.; Tipping, M. J.; Nikolov, D. B.
    Life Science Alliance (2025)

    Fulltext@MSK | Save
  • Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells
    Journal Article

    Saha, N.; Lee, S. G.; Brockmann, E. C.; de la Cruz, M. J.; Goldgur, Y.; Mendoza, R. P.; de Stanchina, E.; Love, T. M.; Marvald, J.; Xu, Y.; more...
    Biomedicine and Pharmacotherapy (2024)

    Fulltext@MSK | Save
  • The angiopoietin signaling pathway is involved in inflammatory processes in hospitalized COVID-19 patients
    Journal Article

    Mendoza, R. P.; Momeni, A.; Saha, N.; Arshi, J.; Gabutan, E. C.; Alejandro, N.; Zuretti, A.; Premsrirut, P. K.; Nikolov, D. B.
    Microorganisms (2023)

    Fulltext@MSK | Save
  • Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells
    Journal Article

    Saha, N.; Baek, D. S.; Mendoza, R. P.; Robev, D.; Xu, Y.; Goldgur, Y.; De La Cruz, M. J.; de Stanchina, E.; Janes, P. W.; Xu, K.; more...
    Biomedicine and Pharmacotherapy (2023)

    Fulltext@MSK | Save
  • Preferential antibody and drug conjugate targeting of the ADAM10 metalloprotease in tumours
    Journal Article

    Yan, H.; Vail, M. E.; Hii, L.; Guo, N.; McMurrick, P. J.; Oliva, K.; Wilkins, S.; Saha, N.; Nikolov, D. B.; Lee, F. T.; more...
    Cancers (2022)

    Fulltext@MSK | Save
  • Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells
    Journal Article

    Saha, N.; Xu, K.; Zhu, Z.; Robev, D.; Kalidindi, T.; Xu, Y.; Himanen, J.; de Stanchina, E.; Pillarsetty, N. V. K.; Dimitrov, D. S.; more...
    Translational Oncology (2022)

    Fulltext@MSK | Save
  • The EphB2 receptor uses homotypic, head-to-tail interactions within its ectodomain as an autoinhibitory control mechanism
    Journal Article

    Xu, Y.; Robev, D.; Saha, N.; Wang, B.; Dalva, M. B.; Xu, K.; Himanen, J. P.; Nikolov, D. B.
    International Journal of Molecular Sciences (2021)

    Fulltext@MSK | Save
  • Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19
    Journal Article

    Mendoza, R.; Saha, N.; Momeni, A.; Gabutan, E.; Alawad, M.; Dehghani, A.; Diks, J.; Lin, B.; Wang, D.; Alshal, M.; more...
    Heliyon (2021)

    Fulltext@MSK | Save
  • ADAM proteases: Emerging role and targeting of the non-catalytic domains
    Review

    Saha, N.; Robev, D.; Himanen, J. P.; Nikolov, D. B.
    Cancer Letters (2019)

    Fulltext@MSK | Save
  • Therapeutic potential of targeting the Eph/ephrin signaling complex
    Journal Article

    Saha, N.; Robev, D.; Mason, E. O.; Himanen, J. P.; Nikolov, D. B.
    International Journal of Biochemistry and Cell Biology (2018)

    Fulltext@MSK | Save